May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Intrinsic Tgfβ/Gadd45b NeuroprotectivePathway in Retinal Ganglion Cells
Author Affiliations & Notes
  • B. Liu
    Ophthalmology, The Frosythe Laboratory for the Investigation of the Aging Retina, Northwestern University, Chicago, Illinois
  • G. Suyeoka
    Ophthalmology, The Frosythe Laboratory for the Investigation of the Aging Retina, Northwestern University, Chicago, Illinois
  • A. H. Neufeld
    Ophthalmology, The Frosythe Laboratory for the Investigation of the Aging Retina, Northwestern University, Chicago, Illinois
  • Footnotes
    Commercial Relationships  B. Liu, None; G. Suyeoka, None; A.H. Neufeld, None.
  • Footnotes
    Support  NIH Grant EY12017, the Forsythe Foundation, and RPE Grant
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5506. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B. Liu, G. Suyeoka, A. H. Neufeld; Intrinsic Tgfβ/Gadd45b NeuroprotectivePathway in Retinal Ganglion Cells. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5506. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We hypothesize that retinal ganglion cells (RGCs) have intrinsic neuroprotective mechanisms that can be potentiated to increase their resistance to injury, as in glaucoma. Growth arrest and DNA damage inducible protein 45b (Gadd45b) is an anti-apoptosis protein important in cell survival in response to genotoxic stresses and apoptotic cytokines. We previously found that Gadd45b was upregulated by TGFβ signaling in RGCs. In this study, we demonstrate the neuroprotective function of the TGFβ/Gadd45b pathway and identify modulators that potentiate TGFβ/Gadd45b signaling in RGCs.

Methods: : Gadd45b expression was detected by immunohistochemistry in retinas of glaucoma rat models. RGC5 cells were used for studies in vitro. Gadd45b SiRNA was transfected into RGC5 cells to knockdown Gadd45b. Gadd45b mRNA expression in RGC5 cells was detected by quantitative real time RT-PCR. The neuroprotective function of TGFβ/Gadd45b was demonstrated by comparing viable cell number among control, Gadd45b knockdown and TGFβ1 treated RGC5 cells exposed to TNFα cytotoxicity, glutamate excitotoxicity or paraquat oxidative stress. The modulation of the TGFβ/Gadd45b signal pathway was detected by immunoblot.

Results: : Gadd45b expression is specifically upregulated in RGCs in eyes with chronic, moderately elevated intraocular pressure compared to control eyes. Gadd45b expression is apparently induced by TGFβ signaling of RGCs in glaucomatous retinas. Comparing control and Gadd45b-knockdown RGC5 cells, knockdown of Gadd45b expression causes a much greater loss of RGC5 cells in response to TNFα cytotoxicity, glutamate excitotoxicity or paraquat oxidative stress. In TGFβ1 induced neuroprotection, induction of Gadd45b is an important component to protect cells from death. Co-treatment with resveratrol significantly potentiates the expression of Gadd45b and the neuroprotective effects of TGFβ1 against TNFα cytotoxicity in RGC5. Resveratrol modulates the TGFβ/Gadd45b signal transduction pathway by quickly increasing TGFβ receptor I and decrease TGFβ receptor II levels in RGC5 cells.

Conclusions: : Gadd45b is an intrinsic, neuroprotective molecule that protects RGCs against mulitiple neuronal injuries. Gadd45b is induced by TGFβ signaling and can by potentiated by resveratrol. Resveratrol potentiates the TGFβ/Gadd45b signaling and the neuroprotective effect by increasing TGFβ receptor I level. Our findings provide a neuroprotective strategy to potentiate an intrinsic neuroprotective mechanism in RGCs for the treatment of glaucoma and possibly other neurodegenerations as well.

Keywords: neuroprotection • ganglion cells • cell survival 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×